IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis

European Journal of Immunology

Volumn 28, Issue 9, 1998, Pages 2780-2790

  Inobe, Jun Ichi ^a   Slavin, Anthony J ^a   Komagata, Yoshinori ^a   Chen, Youhai ^a   Liu, Liming ^a   Weiner, Howard L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Autoimmunity; IL 4; Th3 cell; Tolerance; Transforming growth factor

Indexed keywords

CYTOKINE ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 2; INTERLEUKIN 4; MYELIN BASIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HELPER CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL;

ADMINISTRATION, ORAL; ANIMALS; AUTOIMMUNITY; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNE TOLERANCE; INTERLEUKIN-4; MICE; MICE, TRANSGENIC; MYELIN BASIC PROTEINS; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031716664     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199809)28:09<2780::AID-IMMU2780>3.0.CO;2-J     Document Type: Article

References (35)

1. Chase, M., Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 1946. 61: 257-259.
2. Mowat, A. M., The regulation of immune responses to dietary protein antigens. Immunol. Today 1987. 8: 93-98.
3. + cells mediate active suppression. J. Immunol. 1995. 155: 910-916.
4. Whitacre, C. C., Gienapp, I. E., Orosz, C. G. and Bitar, D., Oral tolerance in experimental autoimmune encephalomyelits. III. Evidence for clonal anergy. J. Immunol. 1991. 147: 2155-2163.
5. Friedman, A. and Weiner, H., Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 1994. 91: 6688-6692.
6. Chen, Y., Kuchroo, V. K., Inobe, J.-L., Hafler, D. A. and Weiner, H. L., Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994. 265: 1237-1240.
7. Weiner, H. L., Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 1997. 18: 335-343.
8. Fukaura, H., Kent, S. C., Pietrusewicz, M. J., Khoury, S. J., Weiner, H. L. and Hafler, D. A., Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-betal-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 1996. 98: 70-77.
9. Kim. P.-II. and Kagnoff, M. F., Transforming growth factor-β1 is a costimulator for IgA production. J. Immunol. 1990. 144: 3411-3416.
10. Chin, Y. H., Cai, J. P. and Xu, X. M., Transforming growth factor-β1 and IL-4 regulate the adhesiveness of Peyer's patch high endothelial venule cells for lymphocytes. J. Immunol. 1992. 148: 1106-1112.
11. Khoury, S. J., Hancock, W. W. and Weiner, H. L., Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis as associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interieukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 1992. 176: 1355-1364.
12. Chen, Y., Hancock, W. W., Marks, R., Gonnella, P. A. and Weiner, H. L., Mechanisms of recovery from experimental allergic encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice. J. Neuroimmunol. 1998. 82: 149-159.
13. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 1994. 179: 589-600.
14. Neurath, M. F., Fuss, I., Kelsall, B. L., Presky, D. H., Waegell, W. and Strober, W., Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 1996. 183: 2605-2616.
15. + T cell line. J. Exp. Med. 1997. 185: 1769-1775.
16. LeGros, G., Ben-Sasson, S. Z., Seder, R. A., Finkelman, F. D. and Paul, W. E., Generation of interleukin 4 (IL-4) producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J. Exp. Med. 1990. 172: 921-929.
17. + T cells through IL-12 produced by Listenia-induced macrophages. Science 1993. 260: 547-549.
18. Zhang, Z. and Michael, J. G., Orally inducible immune unresponsiveness is abrogated by IFN-γ treatment. J. Immunol. 1990. 144: 4163-4165.
19. Marth, T., Strober, W. and Kelsall, B. L., High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J. Immunol. 1996. 157: 2348-2357.
20. Daynes, R., Araneo, B., Dowell, T., Huang, K. and Dudley, D., Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J. Exp. Med. 1990. 171: 979-996.
21. Rollwagen, F. M. and Baqar, S., Oral cytokine administration. Immunol. Today 1996. 17: 548-550.
22. Rizzo, L. V., Miller-Rivero, N. E., Chan, C.-C., Wiggert, B., Nussenblatt, R. B and Caspi, R. R., Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Invest. 1994. 94: 1668-1672.
23. Sun, J.-B., Holmgren, C. and Czerkinsky, C., Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 1994. 91: 10795-10799.
24. Elson, C. O., Tomasi, M., Dertzbaugh, M. T., Thaggard, G., Hunter, R. and Weaver, C., Oral antigen delivery by way of a multiple emulsion system enhances oral tolerance. In Weiner, H. L. and Mayer, L. F. (Eds.), Oral Tolerance: Mechanisms and Applications, Annals New York Academy of Sciences, New York 1996, p. 156-162.
25. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M. and Röcken, M., Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994. 180: 1961-1966.
26. + T cells. J. Exp. Med. 1996. 183: 2669-2674.
27. + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor beta. J. Immunol. 1991. 146: 1163-1168.
28. Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Annunziata, N. and Doetschman, T., Targeted disruption of the mouse transforming growth factor-B1 gene results in multifocal inflammatory disease. Nature 1992. 359: 693-699.
29. Chen, Y., Inobe, J.-I., Marks, R., Gonnella, P., Kuchroo, V. K. and Weiner, H. L., Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995 376: 177-180.
30. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production. J. Immunol. 1998, in press.
31. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737-742.
32. Lafaille, J., Nagashima, K., Katsuki, M. and Tonegawa, S., High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994. 78: 399-408.
33. Chen, Y., Inobe, J., Kuchroo, V. K., Baron, J. L., Janeway, C. A., Jr. and Weiner, H. L., Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA 1996. 93: 388-391.
34. Deibler, G. E., Martenson, R. E. and Kies, M. W., Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 1972. 2: 139-165.
35. Platzer, C., Richter, G., Uberla, K., Muller, W., Blocker, H., Diamantstein, T. and Blankenstein, T., Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur. J. Immunol. 1992. 22: 1179-1184.